Key result
Higher TAPS/PASP ratio (HR 0.689 per 1-SD increase) and elevated lactate (HR 1.498 per 1-SD increase) were independently associated with 28-day mortality, and their combination yielded superior predictive performance (AUC 0.703) in patients with cardiogenic shock.
Why the study?
Cardiogenic shock carries high mortality, and effective risk stratification is crucial for guiding management.
Does the combined assessment of TAPS/PASP ratio and lactate levels predict 28-day mortality in ICU patients with cardiogenic shock?
Cohort (n=221)
No
Does the combined assessment of TAPS/PASP ratio and lactate levels predict 28-day mortality in ICU patients with cardiogenic shock?
Hazard Ratio: 0.689 (95% CI 0.53–0.89)
p-value: p=0.003
The combined assessment of TAPS/PASP ratio and lactate levels provides enhanced prognostic information and improves risk stratification for 28-day mortality in patients with cardiogenic shock.
Combined TAPSE/PASP-lactate assessment may refine CS risk stratification; leaves open prospective validation before clinical adoption.
BACKGROUND: Cardiogenic shock (CS) remains a high-mortality condition. Effective risk stratification is crucial for guiding management. This study evaluated the combined prognostic utility of the tricuspid annular plane systolic excursion(TAPS) to pulmonary artery systolic pressure (PASP) ratio, a measure of right ventricular-pulmonary coupling, and lactate, a marker of tissue hypoperfusion, in intensive care unit (ICU) patients with CS. METHODS: A retrospective cohort study was conducted on 221 ICU patients diagnosed with CS (SCAI shock stages B-E). Echocardiographic parameters (including TAPS/PASP) and arterial lactate levels were obtained within 24 h of diagnosis. The primary outcome was 28-day mortality. Univariate and multivariate Cox proportional hazards regression, Kaplan-Meier survival analysis, and receiver operating characteristic (ROC) curve analysis were performed. RESULTS: Both TAPS/PASP ratio (HR = 0.689, p = 0.003) and lactate (HR = 1.498, p = 0.003) were independently associated with 28-day mortality. Patients with low TAPS/PASP and high lactate had significantly lower survival. A combined model incorporating both parameters demonstrated superior predictive performance for 28-day mortality (AUC = 0.703) compared to TAPS/PASP (AUC = 0.671) or lactate (AUC = 0.650) alone. A non-linear relationship was observed between TAPS/PASP and lactate. CONCLUSION: The combined assessment of TAPS/PASP ratio and lactate levels provides enhanced prognostic information in patients with cardiogenic shock. This integrated approach, incorporating both cardiac function and metabolic biomarkers, may improve risk stratification and facilitate more targeted therapeutic interventions in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) conducted a cohort in Cardiogenic shock (n=221). TAPS/PASP ratio and lactate levels vs. Lower TAPS/PASP ratio and lower lactate levels was evaluated on 28-day mortality (HR 0.689, 95% CI 0.53-0.89, p=0.003). Higher TAPS/PASP ratio (HR 0.689 per 1-SD increase) and elevated lactate (HR 1.498 per 1-SD increase) were independently associated with 28-day mortality, and their combination yielded superior predictive performance (AUC 0.703) in patients with cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: